The emerging therapy of the medication represents a major advance in the management of diabetes mellitus type 2. Distinct from existing therapies, tirzepatide affects multiple pathways – the GLP-1 hormone and GIP – https://tirzepatidepeptide503947.thekatyblog.com/40192264/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment